Home
>
National Drug Code (NDC)
>
Actoplus Met
Actoplus Met - 55154-5153-2 - (pioglitazone hydrochloride and metformin hydrochloride)
Drug Information of Actoplus Met
| Product NDC: | 55154-5153 |
| Proprietary Name: | Actoplus Met |
| Non Proprietary Name: | pioglitazone hydrochloride and metformin hydrochloride |
| Active Ingredient(s): | 850; 15 mg/1; mg/1 & nbsp; pioglitazone hydrochloride and metformin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Actoplus Met
| Product NDC: | 55154-5153 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021842 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050829 |
Package Information of Actoplus Met
| Package NDC: | 55154-5153-2 |
| Package Description: | 720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-5153-2) |
NDC Information of Actoplus Met
| NDC Code | 55154-5153-2 |
| Proprietary Name | Actoplus Met |
| Package Description | 720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-5153-2) |
| Product NDC | 55154-5153 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pioglitazone hydrochloride and metformin hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050829 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 850; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
